Biological and biochemical characterization of mice expressing prion protein devoid of the Octapeptide repeat region after infection with prions

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Yamaguchi, Yoshitaka ^a,b   Miyata, Hironori ^c   Uchiyama, Keiji ^a   Ootsuyama, Akira ^c   Inubushi, Sachiko ^a   Mori, Tsuyoshi ^a   Muramatsu, Naomi ^a   Katamine, Shigeru ^b   Sakaguchi, Suehiro ^a,b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BIOCHEMISTRY; BRAIN REGION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; INCUBATION TIME; MOUSE; NONHUMAN; OCTAPEPTIDE REPEAT; PATHOGENESIS; PRION; PRION DISEASE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SCRAPIE AGENT; SPINAL CORD; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; DISEASE SUSCEPTIBILITY; ENDOPEPTIDASE K; FORELIMB; GENE EXPRESSION REGULATION; LYSINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGOPEPTIDES; PARESIS; PRIONS; REPETITIVE SEQUENCES, AMINO ACID; SCRAPIE; SEQUENCE DELETION;

EID: 84865154931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043540     Document Type: Article

References (24)

1. Prusiner SB, (1998) Prions. Proc Natl Acad Sci U S A 95: 13363-13383.
2. Weissmann C, Enari M, Klohn PC, Rossi D, Flechsig E, (2002) Molecular biology of prions. Acta Neurobiol Exp (Wars) 62: 153-166.
3. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
4. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
5. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, et al. (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A 90: 10608-10612.
6. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J, (1994) PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3: 331-340.
7. Sakaguchi S, Katamine S, Shigematsu K, Nakatani A, Moriuchi R, et al. (1995) Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent. J Virol 69: 7586-7592.
8. Stahl N, Borchelt DR, Hsiao K, Prusiner SB, (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51: 229-240.
9. Flechsig E, Shmerling D, Hegyi I, Raeber AJ, Fischer M, et al. (2000) Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27: 399-408.
10. Supattapone S, Muramoto T, Legname G, Mehlhorn I, Cohen FE, et al. (2001) Identification of two prion protein regions that modify scrapie incubation time. J Virol 75: 1408-1413.
11. Supattapone S, Bosque P, Muramoto T, Wille H, Aagaard C, et al. (1999) Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell 96: 869-878.
12. Yoshikawa D, Yamaguchi N, Ishibashi D, Yamanaka H, Okimura N, et al. (2008) Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice. J Biol Chem 283: 24202-24211.
13. Fujita K, Yamaguchi Y, Mori T, Muramatsu N, Miyamoto T, et al. (2011) Effects of a Brain-Engraftable Microglial Cell Line Expressing Anti-Prion scFv Antibodies on Survival Times of Mice Infected with Scrapie Prions. Cellular and Molecular Neurobiology 31: 999-1008.
14. Reed J, Muench H, (1938) A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27: 493-497.
15. Weissmann C, Flechsig E, (2003) PrP knock-out and PrP transgenic mice in prion research. British Medical Bulletin 66: 43-60.
16. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J 15: 1255-1264.
17. Brown DR, Qin K, Herms JW, Madlung A, Manson J, et al. (1997) The cellular prion protein binds copper in vivo. Nature 390: 684-687.
18. Warner RG, Hundt C, Weiss S, Turnbull JE, (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 277: 18421-18430.
19. Priola SA, Caughey B, (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 8: 113-120.
20. Bruce ME, Fraser H, (1991) Scrapie strain variation and its implications. Current topics in Microbiology and Immunology 172: 125-138.
21. Chien P, Weissman JS, (2001) Conformational diversity in a yeast prion dictates its seeding specificity. Nature 410: 223-227.
22. Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, et al. (2011) Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta neuropathologica 121: 79-90.
23. Bessen RA, Marsh RF, (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. Journal of Virology 66: 2096-2101.
24. Bessen RA, Marsh RF, (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. Journal of Virology 68: 7859-7868.